New Plasma Caucus in the House

A new plasma user’s caucus has been established in the 118th Congress. It is composed of legislators who have identified the American plasma supply as an important issue for Americans. Although the number of Americans with hemophilia B using plasma derived therapies is very small, there are still some patients who use them. In addition, there are many Americans with a variety of other conditions who need these treatments. This represents significant recognition of the importance of plasma to the American people. Currently the caucus is made up of a small number of legislators but it is expected that others will be recruited over time. The Coalition for Hemophilia B works closely with a variety of other patient organizations to ensure that plasma receives appropriate attention.